Replies to post #217888 on Biotech Values

[DewDiligence]

EARS -27% on purportedly positive phase-1 results in healthy volunteers:

https://globenewswire.com/news-release/2018/10/17/1622487/0/en/Auris-Medical-Announces-Positive-Results-From-Second-Phase-1-Clinical-Trial-With-Intranasal-Betahistine.html

[DewDiligence]

EARS is trying again in tinnitus:

https://www.globenewswire.com/news-release/2019/09/13/1915411/0/en/Auris-Medical-Receives-FDA-and-EMA-Guidance-for-Keyzilen-Late-Stage-Clinical-Development-Program.html

Why do they expect a different (i.e. successful) outcome?